Discovering a novel therapy for disorders that feature defects of the neuromuscular junction structure
<p><b>Background:</b> Congenital myasthenic syndromes (CMS) are a group of inherited disorders that affect signal transmission at the neuromuscular junction (NMJ) and share the clinical feature of fatigable muscle weakness. Downstream of tyrosine kinase 7 (DOK7) is a cytoplasmic-ad...
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | Tese |
| Idioma: | English |
| Publicado em: |
2020
|
| Assuntos: |